A Professor of Research at the Keck School of Medicine of the University of Southern California in its Department of Pediatrics and an Adjunct Professor of Pediatrics in the Selçuklu School of Medicine, Selçuk University in Konya, Turkey, Dr. Fatih Uckun has previously served for 13 years as a researcher and professor at the University of Minnesota. His medical interests lie in developmental therapeutics and biopharmaceuticals, especially in the area of pediatric cancers and leukemia.
Dr. Fatih Uckun has co-authored more than 470 papers in peer-reviewed journals such as Science, Nature, New England Journal of Medicine, and the Proceedings of the National Academy of Sciences. The U.S. Patent Office and its European counterpart have recognized more than 83 inventions devised by Dr. Fatih Uckun. These include tyrosine kinase inhibitors, natural compounds, and organic metallic compounds against cancer. Much in demand as a lecturer, Dr. Fatih Uckun will give presentations in 2011 on such topics as nanomedicine and cancer nanotechnology at Providence Saint Joseph Medical Center in Burbank and the Gordon Research Conference in Waterville, Maine.
Dr. Fatih Uckun holds memberships in the American Association for Cancer Research (AACR), the American Society of Hematology (ASH), and the Radiation Research Society (RRS). In 1996, the American Society for Clinical Investigation (ASCI), a prestigious honor society of physician-scientists, recognized Dr. Fatih Uckun’s achievements by admitting him to membership. Since then, he has become a member of the American Society of Clinical Oncology (ASCO). Dr. Fatih Uckun has worked with government agencies, including his current affiliation with the NCI Alliance for Nanotechnology in Cancer, and in the past, the U.S. Department of Defense and DARPA (Defense Advanced Research Projects Agency), serving as a Principal Investigator on a Virus Neutralizer Research Project grant
He is a senior physician-scientist who currently holds the academic post of Professor of Research in the Department of Pediatrics in the Keck School of Medicine of the University of Southern California. In addition, he serves as the Head of Translational Research in Leukemia and Lymphoma and the Leader of the Developmental Therapeutics Program within the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles.
Dr. Fatih Uckun also heads a federally funded Nanomedicine Research & Development Program at the Children’s Hospital Los Angeles. This program is affiliated with the National Cancer Institute Alliance on Nanotechnology against Cancer. Among his many ongoing duties, Dr. Fatih Uckun serves as a member of the Developmental Therapeutics Program Working Group of the USC Norris Comprehensive Cancer Center.
Dr. Fatih Uckun belongs to a number of medical associations, including the American Society for Clinical Investigation, an honor society for leading physician-scientists. He holds patents for more than 80 inventions, received numerous awards, including the Stohlman Memorial Award, the highest honor given by the Leukemia Society of America to its most productive scholars and has lectured at many prestigious organizations and conferences. He has published more than 400 articles in most prestigious peer-reviewed journals and written chapters for nearly 30 books, on many topics.